[Aspects of defibrinogenation therapy].
Fibrinolysis threatment works by means of enzymatic action. It is an effective therapy for occlusive disease of the arteries at Fontaine's stages III and IV. New developments in this treatment will be of interest to phlebologists in the near future. No studies have been reported in the world literature that broaden the present indications : critical study is still required.
D000721:Ancrod / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D010450:Endopeptidases / Q000627:therapeutic use*; D006801:Humans; D013924:Thrombophlebitis / Q000188:drug therapy*
D010450:Endopeptidases; D000721:Ancrod
Quelques aspects de la thérapie par défibrinogénation